Patients´preferences for systemic treatment of atopic dermatitis

• Conditions: Atopic dermatitis; L20

• Registration Number: DRKS00025064
• Lead Sponsor: Klinik für Dermatologie, Venerologie und Allergologie Universitätsmedizin Mannheim.

Brief Summary

Participants attached great importance to safety and symptom control. However, preferences were also dependent on individual characteristics, underscoring the importance of personal counseling. Conjoined with medical considerations, patients' preferences have fundamental impact on shared decisions for treatment of atopic dermatitis.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-15
• Study Completion: 2022-03-29
• Results First Posted: 2024-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 194

Inclusion Criteria

• Presence of a medically diagnosed atopic dermatitis
• Age = 18 years
• Consent to participate in the study

Exclusion Criteria

Minority, lack of consent to participate in the study

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Conjoint analysis is used to examine which properties of the established and new therapies are particularly important from the perspective of patients with neurodermatitis.

Secondary Outcome Measures

Name	Time	Method
Secondary study objectives are to determine the influence of patient characteristics on these preferences.